Substance Use Disorders Clinical Trial
Official title:
Effects of Core Stabilization Exercises on Pulmonary Functions, Respiratory Muscle Strength and Functional Capacity in Adolescents With Substance Use Disorder. A Randomized Controlled Study
In recent years adolescent substance abuse is a serious and growing problem. Substance use
among adolescents means the use of alcohol, opiates, amphetamines, inhalants, cocaine,
marijuana, benzodiazepines, hallucinogens, and anabolic steroids. The United Nations Office
on Drugs and Crime reports that approximately 5% of the world's population used an illicit
drug in 2010 and it is estimated that heroin, cocaine and other drugs are responsible for 0.1
to 0.2 million deaths per year.
There is a limited number of studies in the literature that investigate the relationship
between substance use disorder and respiratory functions. In Taylor et al., study reported
that the proportion of cannabis-dependent study members with an FEV1/FVC ratio of, 80% was
36% compared to 20% for non-smokers. Another research of Taylor et al., in longitudinal
observations over 8 years in young adults (cannabis smoking on lung function in young adults
between the ages of 18 and 26) revealed a dose-dependent relationship between cumulative
cannabis consumption and decline in FEV1/VC. In a monograph, stated that follow-up studies of
regular cannabis-only smokers also found impaired respiratory function and pathological
changes in lung tissue like those preceding the development of chronic obstructive pulmonary
disease .
The core anatomically described as a box, with the abdominals at the front, spinal and
gluteal muscles at the back, the diaphragm on the top, and the pelvic floor and hip muscles
on the bottom. Correct breathing is vital to abdominal training because respiratory muscles
are directly involved during common core stability exercises. Moreover, the diaphragm, a
component of core stability, plays a role in respiration and trunk stability by controlling
intra-abdominal pressure . Oh et al.reported that, 30-min, 3 days a week for 8 weeks lumbar
stabilization exercise had a more positive effect on pulmonary function than general physical
therapy on stroke patients.
Our hypothesis was that core exercises may positive effect on respiratory functions and
functional capacity of substance use disorder individuals. The aim of our study is to
investigate the effects of core exercises on respiratory functions and functional capacity in
adolescents with substance use disorder.
Subjects: The study sample comprised of 15-18 year old male. Participants were required to be
in-residence at the treatment center and meet Diagnostic and Statistical Manual-V criteria
for substance use disorder in Mental Health and Neurological Diseases Training and Research
Hospital for Psychiatry, Neurology and Neurosurgery; Child and Adolescent Drug and Alcohol
Dependence Treatment Center (CEMATEM) in Istanbul.
Sample Size Determination: The sample size and power calculations were performed using the
Instat sample size calculator. The calculations were based on the average value of the
6-Minute Walk Test in the 15-20 age group was 725.8 meters and the standard deviation (SD)
was 61.2 meters (28), in the 95% confidence interval, an alpha level of 0.05, a β level of 5%
and a power of 95%.These parameters generated a sample size of at least 18 participants for
each group.
Randomization Study Protocol: The participants were randomly assigned to 1 of 2 parallel
groups to receive either Exercise or Control. To allocate the participants to the groups,
using the method of randomly permuted blocks using Research Randomizer, a program published
on a publicly accessible official website (www.randomizer.org). Computerized random numbers
were conducted, and sequentially numbered index cards with the random assignment were
prepared. The index cards were folded and placed in sealed, opaque envelopes. Then, the
investigator opened each envelope and allocated the participants to the Exercise or control
group according to the selected index card.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05660434 -
Using Aromatherapy in Substance Use Disorder
|
N/A | |
Active, not recruiting |
NCT05338268 -
Substance Use and Loneliness
|
N/A | |
Completed |
NCT03954184 -
E-health Implementation (Iowa)
|
N/A | |
Completed |
NCT04098614 -
Barriers to Substance Use Disorder Recovery
|
N/A | |
Completed |
NCT03590106 -
Cardiac Surgery Peer Recovery Support Program
|
N/A | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Recruiting |
NCT06273228 -
Parenting Young Children in Pediatrics
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT04401215 -
Technologically-Augmented Referrals to Mitigate Addiction Consequences
|
N/A | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT06187701 -
Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Active, not recruiting |
NCT02382042 -
Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans
|
N/A | |
Terminated |
NCT01356667 -
Drum-Assisted Therapy for Native Americans
|
N/A | |
Completed |
NCT01237366 -
Study Targeting Affect Regulation
|
Phase 1/Phase 2 | |
Completed |
NCT00708890 -
Twelve Step Based Self-help Groups for Substance Related Disorders
|
N/A | |
Active, not recruiting |
NCT04048850 -
Zepatier in Patients With Substance Use
|
||
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 |